Faculty disclosure

Targeting

HERZ:

SEMINARS IN ONCOLOGY Recent Developments and Future for Breast Cancer Patients Faculty

Robert W. Akita Employee, stock shareholder, Genentech. Carlos L. Arteaga, MD Grant or research support, Bristol-Myers Genentech; speakers bureau, Genentech; bureau, paid consultant, AstraZeneca. Gabriel N. Hortobagyi, MD, FACP Paid consultant, honoraria, Bristol-Myers honoraria, Genentech, Roche. Mien-Chie Hung, PhD Grant or research support, honorarium, Bristol-Myers Aventis. Elicia Penuel, PhD Employee, stock shareholder,

Squibb, speakers

Squibb;

paid consultant, Squibb, Genentech,

Disclosure The following authors report no significant financial interest or other relationship with the manufacturer(s) of any of the products or provider(s) of any of the services included in their manuscripts or with Genentech, Inc., its subsidiaries or business partners: Mary Beth Carter, BS Wichai Chinratanalab, MD, MS Mary L. Disis, MD Caroline Lohrisch, MD, FRCPC Kathy S. Schiffman, PAC Shao-Chun Wang, PhD Lisha Zhang, PhD

Genentech.

Martine J. Piccart, MD, PhD Grant or research support, Genentech; advisory board, Roche Pharmaceuticals. Gabriele Schaefer, PhD Employee, stock shareholder, Genentech. Mark X. Sliwkowski, PhD Grant or research support, speakers bureau, employee, Genentech; consultant, Rhone-Poulenc Rorer; grant or research support, speaker’s bureau, paid consultant, Bristol-Myers Squibb.

56

Directions

Institutional

Disclosure

The Center for Biomedical Continuing Education receives educational grants from the pharmaceutical industry and other commercial sources. Companies providing grants to The Center for Biomedical Continuing Education include the commercial supporter(s) of this activity as well as the manufacturer(s) of certain drugs and/or devices discussed in this activity.